Clinical Efficacy of Thumbtack Needle for Chronic Insomnia in Perimenopausal and Menopausal Women
Condition(s) studied
Investigational drug(s) / intervention(s)
thumbtack needle: The treatment acupoints include bilateral Anmian Acupoint, bilateral Taichong acupoints, bilateral Neiguan acupoints, bilateral Sanyinjiao (SP6), and bilateral Zusanli (ST36) and Danzhong acupoints, a total of 11 acupoints. After 3 days of thumbtack needle retention, the patient went to the hospital where the doctor removed the thumbtack needle, disinfected the local skin, and received the next needle treatment. The patient received treatment twice a week (6 days) and rested for 1 day before continuing with the next treatment.
placebo thumbtack needle: The placebo thumbtack needle group selected acupoints that were the same as the thumbtack needle group. Bilateral sleeping acupoints, bilateral Taichong acupoints, bilateral Neiguan acupoints, bilateral Sanyinjiao (SP6), bilateral Zusanli (ST36), and Danzhong acupoints are all treated with comforting acupressure.where the doctor removed the placebo thumbtack needle, disinfected the local skin, and received the next placebo thumbtack needle needle. The patient received treatment twice a week (6 days) and rested for 1 day before continuing with the next treatment.
Study summary
A multicenter, randomized, controlled, blinded clinical trial was conducted to evaluate the effects of thumbtack needle on sleep in patients with chronic insomnia during perimenopause and menopause. Randomly divided into a treatment group and a control group using the central area method, with 99 patients in each group. The treatment group received thumbtack needle treatment, while the control group received placebo thumbtack needle treatment. The treatment course for both groups was 4 weeks.
Eligibility
Primary outcome measure(s)
- Insomnia Severity Index — 4 weeks
The Insomnia Severity Index (ISI) is a self-assessment tool used to evaluate the severity of insomnia. The ISI scale consists of 7 items, each rated on a scale of 0-4, with a total score range of 0-28 points. Evaluate the difference in scores between the Insomnia Severity Index (ISI) scale at the end of week 4 and baseline ISI scores.
Trial sites (8)
| Facility | City | Region | Status |
|---|---|---|---|
| Chibi Maternal and Child Health Hospital | Chibi | Hubei | Recruiting |
| Jingzhou Hospital of Traditional Chinese Medicine | Jingzhou | Hubei | Recruiting |
| Qianjiang Central Hospital | Qianjiang | Hubei | Recruiting |
| Wuhan Children's Hospital | Wuhan | Hubei | Recruiting |
| Renmin Hospital of Wuhan University | Wuhan | Hubei | Recruiting |
| Rehabilitation Center, Wuhan Puren Hospital | Wuhan | Hubei | Recruiting |
| Xiaogan Maternal and Child Health Care Hospital | Wuhan | Hubei | Recruiting |
| Aksu Prefecture Maternal and Child Health Hospital | Aksu | XUAR | Recruiting |
More Huazhong University of Science and Technology trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07229976 on ClinicalTrials.gov ↗ ← All trials in China